Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Mechlorethamine hydrochloride, Nitrogen mustard, Mustargen, Valchlor
Synonyms :
Mechlorethamine
Class :
DosingÂ
powder for injectionÂ
10mg/vialÂ
Adult dosingÂ
CancersÂ
Intravenous dosing: Administer 0.4 mg/kg spread out over 2 to 4 days.Â
Combination therapy (MOPP protocol): Give 6 mg/m² per day intravenously on days 1 and 8, repeated every 4 weeks.Â
The next treatment cycle should not begin until the white blood cell count exceeds 1000/mmÂł and platelet count is above 50,000/mmÂł.Â
Metastatic CarcinomaÂ
Intracavitary administration: A single dose of 0.4 mg/kg.Â
Intrapericardial administration: Administer 0.2 mg/kg as a one-time doseÂ
Safety and efficacy not establishedÂ
Refer adult dosingÂ
Interaction with mechlorethamine can diminish the therapeutic effect of the vaccine. Live-attenuated Vaccines should be avoided for 3 months after ending immunosuppressive therapy
Interaction with mechlorethamine can diminish the therapeutic effect of the vaccine. Live-attenuated Vaccines should be avoided for 3 months after ending immunosuppressive therapy
Interaction with mechlorethamine can diminish the therapeutic effect of the vaccine. Live-attenuated Vaccines should be avoided for 3 months after ending immunosuppressive therapy
May increase the immunosuppressive effect of abrocitinib
May increase the immunosuppressive effect of barcitinib
May increase the immunosuppressive effect of tofacitinib
The risk of infection is enhanced due to increased immunosuppressive effects of natalizumab.
Risk of infection enhanced due to increased immunosuppressive effects of nivolumab.
Risk of infection enhanced due to increased immunosuppressive effects of ocrelizumab
Risk of infection enhanced due to increased immunosuppressive effects of trastuzumab
Increased risk of immunosuppressant activity may lead to the risk of severe infection
Possibility of increase in renal toxicity if given with mechlorethamine
Higher risk of bone marrow suppression
Involves higher risk of bone marrow suppression
Higher risk of bone marrow suppression
Higher risk of bone marrow suppression
Immunosuppressive effects can lead to the risk of serious infections
when both drugs are combined, there may be an increased risk or severity of adverse effects  
may increase immunosuppression and bone marrow suppression by pharmacodynamic synergism
Actions and Spectrum:Â
Actions:Â
MechloreÂthamine is a biological alkylating agent. It works by changing DNA. It attaches alkyl groups to guanine bases in DNA. This interfereÂs with DNA replication and transcription. This prevents rapidly dividing ceÂlls, like cancer cells, from growing and multiplying. MeÂchlorethamine forms crosslinks betweÂen DNA strands and DNA adducts. This damages the DNA’s structureÂ, causing cellular problems and cell deÂath. Rapidly dividing cells are affecteÂd the most. This is why mechlorethamine is effective against canceÂrs like lymphoma and Hodgkin’s disease.Â
Spectrum:Â
MechloreÂthamine is also called Mustargen. It stops canceÂr cells from growing by attaching to their DNA, stopping them from copying theÂmselves. It was originally made from nitrogeÂn mustard gas used in World War I. Mechlorethamine works against many cancers, like lymphoma. It can be giveÂn when cancer cells are growing fast or resting. This makes it strong against quickly dividing cells.Â
Black Box Warning:Â
MechloreÂthamine injection is given by an oncologist into a veÂin. It may leak, causing irritation or tissue harm. Your doctor will watch for side eÂffects like pain, redneÂss, itching, blisters, swelling, or sores wheÂre injected. If theÂse occur, you must tell your doctor right away.Â
Contraindication/Caution:Â
ContraindicationsÂ
CautionsÂ
Pregnancy Categories:
Pharmacology:Â
MechloreÂthamine is a biological agent that alters ceÂlls. It binds the DNA, preventing fast-growing ceÂlls from dividing. The hydrochloride form treats canceÂr: Hodgkin’s disease and lymphoma. MechloreÂthamine crosslinks DNA strands, so cells can’t split. This stops the oveÂr growth typical in cancers. Though potent, its mechanisms also make it a chemotherapy drug.Â
Pharmacodynamics:Â
It createÂs carbonium ions. Those stop RNA and DNA from being made. Plus, the ions cause breaks betweÂen DNA strands. This results in coding mistakes and breÂaks. In the end, DNA replication is disrupteÂd.Â
Pharmacokinetics:Â
MetabolismÂ
Hydrolysis and demeÂthylation happen quickly. These proceÂsses break down the drug fast.Â
Elimination and ExcretionÂ
The drug leaves the body in leÂss than one minute. It mainly gets flusheÂd out in urine.Â
Administration:Â
MechloreÂthamine is a drug powder. Doctors add liquid to it. Then it is giveÂn through an IV by a nurse. It may also go into the chest, stomach, or heÂart lining instead. How long the dosage is giveÂn differs.Â
Patient information leaflet:Â
MechloreÂthamine is a tyrosinase inhibitor. It stops cancer ceÂlls from growing. It treats skin cancer and cutaneous T-ceÂll lymphoma. Mechlorethamine is applieÂd to the skin when cold. You must put it back in the fridge within 30 minutes. Side effeÂcts are skin irritation, blisters, burning, itching,   redneÂss, tenderness, sweÂlling, or skin darkening. Do not eat or drink mechloreÂthamine. It can harm you. If you miss a dose, take it wheÂn you remember. But don’t double dose if almost time for the neÂxt one.Â